HUP9902199A1 - Új nitronszármazékok, ezek előállítási eljárása és ezeket tartalmazó gyógyszerkészítmények - Google Patents
Új nitronszármazékok, ezek előállítási eljárása és ezeket tartalmazó gyógyszerkészítményekInfo
- Publication number
- HUP9902199A1 HUP9902199A1 HU9902199A HUP9902199A HUP9902199A1 HU P9902199 A1 HUP9902199 A1 HU P9902199A1 HU 9902199 A HU9902199 A HU 9902199A HU P9902199 A HUP9902199 A HU P9902199A HU P9902199 A1 HUP9902199 A1 HU P9902199A1
- Authority
- HU
- Hungary
- Prior art keywords
- new
- arylalkyl
- preparation
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- CWGBFIRHYJNILV-UHFFFAOYSA-N (1,4-diphenyl-1,2,4-triazol-4-ium-3-yl)-phenylazanide Chemical class C=1C=CC=CC=1[N-]C1=NN(C=2C=CC=CC=2)C=[N+]1C1=CC=CC=C1 CWGBFIRHYJNILV-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 3
- 125000003342 alkenyl group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 125000001072 heteroaryl group Chemical group 0.000 abstract 2
- 125000004446 heteroarylalkyl group Chemical group 0.000 abstract 2
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 230000003078 antioxidant effect Effects 0.000 abstract 1
- 125000005140 aralkylsulfonyl group Chemical group 0.000 abstract 1
- 125000004391 aryl sulfonyl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000007760 free radical scavenging Effects 0.000 abstract 1
- 125000000592 heterocycloalkyl group Chemical group 0.000 abstract 1
- 125000005885 heterocycloalkylalkyl group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- SQDFHQJTAWCFIB-UHFFFAOYSA-N n-methylidenehydroxylamine Chemical class ON=C SQDFHQJTAWCFIB-UHFFFAOYSA-N 0.000 abstract 1
- 230000036542 oxidative stress Effects 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
A találmány (I) általánős képletű új nitrőnszármazékőkra, ezekelőállítási eljárására, valamint ezeket tartalmazógyógyszerkészítményekre vőnatkőzik. A képletben W jelentése aril-, arilalkil-, heterőaril- vagyheterőarilalkilcsőpőrt, amelyek adőtt esetben helyettesítve lehetnek, R1 jelentése alkil-, alkenil-, alkinil-, aril-, ciklőalkil-,arilalkil- vagy ciklőalkilalkilcsőpőrt, amelyek adőtt esetbenhelyettesítve lehetnek, R2 jelentése hidrőgénatőm, alkil-, arilalkil-, ciklőalkil-,ciklőalkilalkil-, heterőciklőalkil-, heterőciklőalkilalkil-,heterőaril-, heterőarilalkil-, acil-, alkilszűlfőnil-, arilszűlfőnil-,arilalkilszűlfőnil- vagy alkenil-csőpőrt. A vegyületek szabadgyökfőgóés antiőxidáns hatásűk következtében őxidációs stressz hatásárakialakűló rendellenességek kezelésére és megelőzésére alkalmazhatók.(I) ŕ
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9808116A FR2780404B1 (fr) | 1998-06-26 | 1998-06-26 | Nouveaux derives de nitrone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (2)
Publication Number | Publication Date |
---|---|
HU9902199D0 HU9902199D0 (en) | 1999-08-30 |
HUP9902199A1 true HUP9902199A1 (hu) | 2000-06-28 |
Family
ID=9527896
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9902199A HUP9902199A1 (hu) | 1998-06-26 | 1999-06-25 | Új nitronszármazékok, ezek előállítási eljárása és ezeket tartalmazó gyógyszerkészítmények |
Country Status (17)
Country | Link |
---|---|
US (1) | US6034250A (hu) |
EP (1) | EP0967207B1 (hu) |
JP (1) | JP2000026428A (hu) |
CN (1) | CN1153766C (hu) |
AT (1) | ATE223904T1 (hu) |
AU (1) | AU747203B2 (hu) |
BR (1) | BR9903282A (hu) |
CA (1) | CA2274621C (hu) |
DE (1) | DE69902851T2 (hu) |
DK (1) | DK0967207T3 (hu) |
ES (1) | ES2183492T3 (hu) |
FR (1) | FR2780404B1 (hu) |
HU (1) | HUP9902199A1 (hu) |
NO (1) | NO312722B1 (hu) |
NZ (1) | NZ336460A (hu) |
PT (1) | PT967207E (hu) |
ZA (1) | ZA994201B (hu) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6096899A (en) * | 1998-04-14 | 2000-08-01 | The Regents Of The University Of Michigan | Cylic imidazole compounds having relatively low hydrogen content and relatively high nitrogen content and polymers formed therefrom |
JP4271445B2 (ja) * | 2001-02-16 | 2009-06-03 | アスビオファーマ株式会社 | Aop−1遺伝子又はaop−1の発現減少を伴う疾患の治療方法及び当該疾患治療薬 |
WO2003010154A1 (en) * | 2001-07-26 | 2003-02-06 | Samsung Electronics Co. Ltd. | Seleno compounds containing nitrone moiety, their preparation and their therapeutic uses |
DK1482931T3 (da) * | 2002-03-05 | 2011-12-19 | Transtech Pharma Inc | Mono- og bicycliske azolderivater der inhiberer interaktionen af ligander med RAGE |
AU2003230770A1 (en) * | 2002-03-28 | 2003-10-13 | Oxis International, Inc. | Neuroprotectant methods, compositions, and screening methods thereof |
ZA200508300B (en) * | 2003-05-20 | 2007-03-28 | Transtech Pharma Inc | RAGE antagonists as agents to reverse amyloidosis and diseases associated therewith |
CN101468970B (zh) | 2008-04-25 | 2011-05-11 | 暨南大学 | 一种硝酮类化合物及其制备方法和在制药中的应用 |
WO2011041198A1 (en) | 2009-09-30 | 2011-04-07 | Transtech Pharma, Inc. | Substituted imidazole derivatives for treatment of alzheimers disease |
JP5885620B2 (ja) * | 2012-08-22 | 2016-03-15 | 四国化成工業株式会社 | 2−(2−フリル)イミダゾール化合物及び酸化防止剤 |
FR3012451B1 (fr) | 2013-10-25 | 2016-11-11 | Michelin & Cie | Compose 1,3-dipolaire portant une fonction imidazole |
FR3012460B1 (fr) | 2013-10-25 | 2015-12-11 | Michelin & Cie | Composition de caoutchouc comprenant un elastomere dienique portant des fonctions imidazole reparties de facon aleatoire le long de la chaine |
FR3012458B1 (fr) | 2013-10-25 | 2015-10-30 | Michelin & Cie | Composition de caoutchouc comprenant un additif compose 1,3-dipolaire portant une fonction imidazole |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0643403B2 (ja) * | 1986-01-25 | 1994-06-08 | 四国化成工業株式会社 | イミダゾール―アルドキシム化合物の合成方法 |
US4803282A (en) * | 1986-08-27 | 1989-02-07 | Pennwalt Corporation | Alpha-substituted ketonitrone derivatives |
WO1992022290A1 (en) * | 1991-06-18 | 1992-12-23 | Oklahoma Medical Research Foundation | Use of spin trapping for the treatment of diseases associated with oxidation of lipids and proteins |
US5455272A (en) * | 1993-10-22 | 1995-10-03 | Oklahoma Medical Research Foundation | Spin trap nitronyl hindered phenols |
AU7739796A (en) * | 1995-11-17 | 1997-06-11 | Florida International University | Azulenyl nitrone spin trapping agents, methods of making and using same |
-
1998
- 1998-06-26 FR FR9808116A patent/FR2780404B1/fr not_active Expired - Fee Related
-
1999
- 1999-06-04 CA CA002274621A patent/CA2274621C/fr not_active Expired - Fee Related
- 1999-06-22 JP JP11175839A patent/JP2000026428A/ja active Pending
- 1999-06-23 NO NO19993122A patent/NO312722B1/no not_active IP Right Cessation
- 1999-06-24 ES ES99401565T patent/ES2183492T3/es not_active Expired - Lifetime
- 1999-06-24 DE DE69902851T patent/DE69902851T2/de not_active Expired - Fee Related
- 1999-06-24 AT AT99401565T patent/ATE223904T1/de not_active IP Right Cessation
- 1999-06-24 PT PT99401565T patent/PT967207E/pt unknown
- 1999-06-24 DK DK99401565T patent/DK0967207T3/da active
- 1999-06-24 EP EP99401565A patent/EP0967207B1/fr not_active Expired - Lifetime
- 1999-06-25 ZA ZA9904201A patent/ZA994201B/xx unknown
- 1999-06-25 CN CNB991112148A patent/CN1153766C/zh not_active Expired - Fee Related
- 1999-06-25 US US09/340,088 patent/US6034250A/en not_active Expired - Fee Related
- 1999-06-25 BR BR9903282-1A patent/BR9903282A/pt not_active IP Right Cessation
- 1999-06-25 AU AU36800/99A patent/AU747203B2/en not_active Ceased
- 1999-06-25 NZ NZ336460A patent/NZ336460A/xx unknown
- 1999-06-25 HU HU9902199A patent/HUP9902199A1/hu not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
FR2780404B1 (fr) | 2001-04-13 |
DK0967207T3 (da) | 2003-01-20 |
JP2000026428A (ja) | 2000-01-25 |
CN1245169A (zh) | 2000-02-23 |
DE69902851T2 (de) | 2003-05-28 |
CA2274621C (fr) | 2004-01-20 |
EP0967207A1 (fr) | 1999-12-29 |
DE69902851D1 (de) | 2002-10-17 |
BR9903282A (pt) | 2000-04-18 |
ES2183492T3 (es) | 2003-03-16 |
NO312722B1 (no) | 2002-06-24 |
NZ336460A (en) | 2000-05-26 |
US6034250A (en) | 2000-03-07 |
CN1153766C (zh) | 2004-06-16 |
AU747203B2 (en) | 2002-05-09 |
ZA994201B (en) | 2000-01-11 |
AU3680099A (en) | 2000-01-13 |
CA2274621A1 (fr) | 1999-12-26 |
NO993122L (no) | 1999-12-27 |
FR2780404A1 (fr) | 1999-12-31 |
NO993122D0 (no) | 1999-06-23 |
HU9902199D0 (en) | 1999-08-30 |
PT967207E (pt) | 2002-12-31 |
EP0967207B1 (fr) | 2002-09-11 |
ATE223904T1 (de) | 2002-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0105437A2 (hu) | Új malonsavszármazékok, előállításuk és alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények | |
HUP0303164A2 (hu) | Kinazolinok mint MMP-13 gátlók, eljárás az előállításukra, intermedierjeik és a vegyületeket tartalmazó gyógyszerkészítmények | |
HUP0402225A2 (hu) | Makrolid-vegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
HUP0102851A2 (hu) | Parazitaellenes artemizinin-származékok (endoperoxidok), eljárás előállításukra és a vegyületeket tartalmazó gyógyászati készítmények | |
HUP0401009A2 (hu) | 5-Hidroxitriptamin-6-ligandumokként alkalmazható 1-aril- vagy 1- alkil-szulfonilbenzazol-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
ES2121441T3 (es) | Nuevos derivados de 3,5 -dioxo - (2h,4h) - 1,2,4 - triazina,su preparacion y aplicacion como farmaco | |
TR200101961T2 (tr) | 1,2-halkalı kinolin türevleri | |
HUP0300080A2 (hu) | Új malonsavszármazékok, eljárás előállításukra, ezek alkalmazása Xa faktor inhibitorként és ezeket tartalmazó gyógyszerkészítmények | |
HUP0401886A2 (hu) | Kemokin receptor aktivitás modulátorokként alkalmazható piperidinszármazékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
HUP9902199A1 (hu) | Új nitronszármazékok, ezek előállítási eljárása és ezeket tartalmazó gyógyszerkészítmények | |
NO20022558L (no) | 4-karboksyamino-2-etyl-1,2,3,4-tetrahydrokinolinkrystall som CETP inhibitor | |
EA200601194A1 (ru) | Новые производные бензофурана, используемые для профилактики или лечения нарушений, связанных с 5-ht-рецептором | |
ATE302778T1 (de) | N-substituierte 4-aminopteridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
ES2036926A1 (es) | "procedimiento para la obtencion de derivados de la (2-alquil-3-piridil)metilpiperazina". | |
DE69008142T2 (de) | 4-Substituierten Imidazolen zur Senkung des intraokularen Druckes. | |
HUP0200580A2 (hu) | Celecoxib polimorf kristályos formái, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
GEP20074256B (en) | Novel benzothiadiazine, process for their preparation and pharmaceutical compositions containing | |
NO20062152L (no) | Fremstilling av 3-azabicyklo [3.1.0.]heksanderivater | |
EA200100090A2 (ru) | Новые пиперидин-4-сульфонамидные производные, способ их получения и содержащие их фармацевтические композиции | |
HUP0004588A2 (hu) | Szubsztituált 1,2,3,4,5,6-hexahidro-2,6-metano-3-benzazocin-10-ol-származékok, eljárás előállításukra és alkalmazásuk gyógyszerként, valamint a vegyületeket tartalmazó gyógyszerkészítmények | |
HUP0402033A2 (hu) | 2-Amino-4-piridil-metil-tiazolin-származékok alkalmazása az indukálható NO-szintetáz inhibitoraként, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
EA200000389A3 (ru) | Новые замещенные пиридины или пиперидины, способ их получения и содержащие их фармацевтические композиции | |
DK0982305T3 (da) | Indan-1-ol-derivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende derivaterne | |
HUP0402585A2 (hu) | Új benzotiazin- benzotiadiazin-származékok, előállításuk, alkalmazásuk és az ezeket tartalmazó gyógyászati készítmények | |
HUP0300265A2 (hu) | Aril- és heteroaril-szulfonátok, eljárás előállításukra és gyógyászati alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC4A | Lapse of provisional application due to refusal |